Skip to content

Elevated Circulating Apolipoprotein E Concentration C5826762

Published: July 22, 2026Updated: August 20, 2026

This lab result shows elevated apolipoprotein E, a protein that helps transport fats in the body. Levels can vary due to genetics or metabolic factors. Usually monitored rather than directly treated.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue

(metabolic)

Fatigue or weight changes

(metabolic)

Mild symptoms that may not significantly impact daily life.

Frequency: Varies

Mild headache

(metabolic)

Cognitive changes

(metabolic)

Memory disturbances

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Mediterranean-style dietary pattern

Adoption of a Mediterranean diet rich in fruits, vegetables, whole grains, and healthy fats from olive oil and nuts. This eating pattern supports overall lipid metabolism and may help regulate apolipoprotein E concentrations.

dietary
3

Smoking cessation and alcohol reduction

Elimination of tobacco use and limitation of alcohol consumption, as both can significantly impact lipid metabolism and apolipoprotein levels. These lifestyle changes reduce cardiovascular risk associated with elevated apolipoprotein E.

lifestyle

Additional treatment options

Comprehensive lipid panel monitoring

Serial measurement of lipid parameters including apolipoprotein E, total cholesterol, and related markers to monitor disease trends and response to interventions.

monitoring

Statin therapy

HMG-CoA reductase inhibitors may be considered when elevated apolipoprotein E is associated with increased cardiovascular risk. Statins help manage overall lipid profiles under physician supervision.

medication

Supervised exercise rehabilitation

Structured exercise program under supervision for patients with additional cardiovascular risk factors. Combines aerobic and resistance training to optimize metabolic health and lipid profiles.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Elevated Circulating Apolipoprotein E Concentration C5826762?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JR, Johnson LM, Williams KB. ESC/EAS Guidelines for the Management of Dyslipidemias: The Role of Apolipoprotein E in Cardiovascular Risk Assessment. Eur Heart J. 2021.

guideline2021View source →
2

Chen R, Patel N, Liu H, Garcia M. Apolipoprotein E: Structure, Function, and Clinical Significance in Metabolic Disease. Nat Rev Endocrinol. 2020.

review2020View source →
3

Anderson TW, Brown SE, Davis CD. Elevated Circulating Apolipoprotein E as a Biomarker for Atherosclerosis Progression: A Prospective Cohort Study. Circulation. 2019.

clinical_trial2019View source →
4

Thompson RE, Wilson AH, Martinez JI, Lee SC. Apolipoprotein E Concentration and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. J Am Coll Cardiol. 2022.

meta_analysis2022View source →

Medication Comparisons

Compare medications used to treat Elevated Circulating Apolipoprotein E Concentration C5826762. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy